Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Alan Faichney, Stephen Chanock, Joseph Fraumeni

Premium

Alan Faichney had joined Arrayjet as non-executive chairman, the UK microarray instrument provider said this week.

Faichney has served as managing director of Concept Systems, an oil exploration company; senior vice president of Ion Geophysical, a seismic solutions firm; chief operating officer at DEM-Solutions, a Scottish software startup; and CEO of Edinburgh Instrumens, a scientific instruments vendor.


The National Cancer Institute has appointed Stephen Chanock to be director of NCI's Division of Cancer Epidemiology and Genetics and a scientific director of the institute.

Chanock takes over DCEG from founding director Joseph Fraumeni, who stepped down from the post a year ago.

Chanock formerly was a tenured investigator in the Genomic Variation Section of the Pediatric Oncology Branch in NCI’s Center for Cancer Research, he was co-chair of NCI's Genetics, Genomics, and Proteomics Faculty, and he was chief of the Cancer Genomics Research Laboratory and the Laboratory of Translational Genomics. He also was acting director of the NCI Center for Cancer Genomics from 2012 to 2013.

BioArray News interviewed Chanock in 2011 about his role in supporting genome-wide association studies (BAN 3/1/2011).

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.